Parameter
|
Log-rank
Test value
|
Degrees of Freedom
|
P
|
---|
Gender
|
1,79
|
1
|
0,1811
|
Age (years)
|
0,34
|
1
|
0,5586
|
PS
|
229,07
|
4
|
<0.001
|
Location
|
10,60
|
2
|
<0.005
|
Grading
|
15,22
|
2
|
<0.005
|
Primary tumor extent
|
40,90
|
3
|
<0.001
|
Distant Metastasis
|
38,80
|
1
|
<0.001
|
Ploidy-group
|
93,79
|
2
|
<0.001
|
Epoetin
|
9,16
|
1
|
0.003
|
Blood Transfusion
|
22,64
|
1
|
<0.001
|
Weight loss
|
178,78
|
3
|
<0.001
|
Pain
|
79,81
|
3
|
<0.001
|
Jaundice
|
6,49
|
1
|
0.01
|
Thrombophlebitis
|
16,87
|
1
|
<0.001
|
Diabetes
|
4,36
|
1
|
0.04
|
Steatorrhoea
|
37,96
|
1
|
<0.001
|
CEA
|
37,51
|
1
|
0.001
|
CA 199
|
1,13
|
1
|
<0.001
|
Amylase
|
6,43
|
1
|
0.01
|
CRP
|
6,95
|
2
|
0.03
|
Albumin
|
54,78
|
1
|
<0.001
|
Therapy
|
161,48
|
3
|
<0.001
|
- PS: Performance Status; CEA, carcinoembryonic antigen; CA 19-9, cancer antigen 19-9; CRP, C-reactive protein.